Martin Pagé

Inhibition of estrogen receptor-DNA binding by the "pure" antiestrogen ICI 164,384 appears to be mediated by impaired receptor dimerization.

Stephen E. Fawell, R White, Susan Hoare et al. · Proceedings of the National Academy of Sciences · 1990 · 402 citations

Medicine, Endocrinology, Pharmacology +17

Discovery and Pharmacological Characterization of JNJ-42756493 (Erdafitinib), a Functionally Selective Small-Molecule FGFR Family Inhibitor

Timothy Perera, Eleonora Jovcheva, Laurence Mévellec et al. · Molecular Cancer Therapeutics · 2017 · 340 citations · Full text

Medicine, Oncology, Pharmacology +17

The characterization of novel, dual ErbB-2/EGFR, tyrosine kinase inhibitors: potential therapy for cancer.

David W. Rusnak, Karen Affleck, Stuart Cockerill et al. · PubMed · 2001 · 297 citations

Medicine, Oncology, Pharmacology +15

JNJ-26481585, a Novel Second-Generation Oral Histone Deacetylase Inhibitor, Shows Broad-Spectrum Preclinical Antitumoral Activity

Janine Arts, Peter King, Ann Marin et al. · Clinical Cancer Research · 2009 · 232 citations

Medicine, Oncology, Pharmacology +12

Proteomic definition of normal human luminal and myoepithelial breast cells purified from reduction mammoplasties

Martin Pagé, Bob Amess, R. Reid Townsend et al. · Proceedings of the National Academy of Sciences · 1999 · 211 citations

Life Sciences, Cell Biology, Molecular Biology +17